Adverse Drug Reaction Classification System

         

ADR Ontology
ADR Term Peritonitis
ADR ID BADD_A03384
ADR Hierarchy
07      Gastrointestinal disorders
07.19      Gastrointestinal infections
07.19.05      Peritoneal infections
07.19.05.004      Peritonitis
11      Infections and infestations
11.01      Infections - pathogen unspecified
11.01.07      Abdominal and gastrointestinal infections
11.01.07.007      Peritonitis
Description INFLAMMATION of the PERITONEUM lining the ABDOMINAL CAVITY as the result of infectious, autoimmune, or chemical processes. Primary peritonitis is due to infection of the PERITONEAL CAVITY via hematogenous or lymphatic spread and without intra-abdominal source. Secondary peritonitis arises from the ABDOMINAL CAVITY itself through RUPTURE or ABSCESS of intra-abdominal organs. [MeSH]
MedDRA Code 10034674
MeSH ID D010538
ADR Severity Grade (FAERS) Not Available
ADR Severity Grade (CTCAE)
Synonym
Acute appendicitis with generalized peritonitis | Acute or unspecified pelvic peritonitis, female | Other chronic pelvic peritonitis, female | Other specified peritonitis | Other suppurative peritonitis | Peritonitis | Peritonitis in infectious diseases classified elsewhere | Peritonitis perforative | Peritonitis suppurative | Peritonitis, unspecified | Suppurative peritonitis, other | Unspecified peritonitis | Pelvic peritonitis | Ascites infection | Peritoneal infection | Fecal peritonitis | Acute peritonitis | Recurrent peritonitis | Infectious peritonitis | Recurrent infectious peritonitis | Faecal peritonitis | Panperitonitis | Septic peritonitis | Pyoperitoneum | Stercoral peritonitis | Secondary Peritonitis | Peritonitis, Secondary | Primary Peritonitis | Peritonitis, Primary
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D01942Riluzole--
BADD_D01956Rivastigmine tartrate--
BADD_D02012Sevelamer--
BADD_D02013Sevelamer carbonate--
BADD_D02014Sevelamer hydrochloride--
BADD_D02028Sirolimus--
BADD_D02105Tacrolimus--
BADD_D02192Thalidomide--
BADD_D02217Tigecycline--
BADD_D02234Tocilizumab--
BADD_D02325Valdecoxib--
BADD_D02334Vandetanib--
BADD_D02369Voriconazole--
The 2th Page    First    Pre   2    Total 2 Pages